Active substance
Flumazenil
- SFDA 3
- US FDA 11
- Health Canada 2
- US price lines 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| ANEXATE 0.5MG AMP 5ML | 0.1 mg/ml | Solution for injection · Intravenous use | 5 Ampoule | SAR 270.65 | NCE · Prescription | CHEPLAPHARM Arzneimittel GmbH | Valid |
| EXITINE | 0.1 mg/ml | Solution for infusion · Intravenous use | 5 Vial | SAR 219.90 | Generic · Prescription | MS Pharma Saudi (MSPS) | Valid |
| Flumazenil PSI | 0.1 mg/ml | Solution for injection/infusion · Intravenous use | 5 Vial | SAR 208.90 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
Indications — CHI Daman Drug Formulary
ANESTHESIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FLUMAZENIL | 1MG/10ML (0.1MG/ML); 0.5MG/5ML (0.1MG/ML) | injectable · injection | HIKMA PHARMS | Prescription | 12 Oct 2004 |
| FLUMAZENIL | 1MG/10ML (0.1MG/ML); 0.5MG/5ML (0.1MG/ML) | injectable · injection | BAXTER HLTHCARE CORP | Prescription | 12 Oct 2004 |
| FLUMAZENIL | 1MG/10ML (0.1MG/ML); 0.5MG/5ML (0.1MG/ML) | injectable · injection | FRESENIUS KABI USA | Prescription | 12 Oct 2004 |
| FLUMAZENIL | 0.5MG/5ML (0.1MG/ML); 1MG/10ML (0.1MG/ML) | injectable · injection | SANDOZ | Prescription | 3 May 2005 |
| FLUMAZENIL | 0.5MG/5ML (0.1MG/ML) | injectable · injection | RISING | Prescription | 13 May 2008 |
| FLUMAZENIL | 0.5MG/5ML (0.1MG/ML); 1MG/10ML (0.1MG/ML) | injectable · injection | HIKMA FARMACEUTICA | Prescription | 23 Mar 2009 |
| FLUMAZENIL | 0.5MG/5ML (0.1MG/ML); 1MG/10ML (0.1MG/ML) | injectable · injection | SAGENT PHARMS | Prescription | 28 Aug 2012 |
| ROMAZICON | 1MG/10ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 0.5MG/5ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | HOFFMANN LA ROCHE | Discontinued | 20 Dec 1991 |
| FLUMAZENIL | 1MG/10ML (0.1MG/ML); 0.5MG/5ML (0.1MG/ML) | injectable · injection | DR REDDYS | Discontinued | 12 Oct 2004 |
| FLUMAZENIL | 1MG/10ML (0.1MG/ML); 0.5MG/5ML (0.1MG/ML) | injectable · injection | HIKMA PHARMS | Discontinued | 12 Oct 2004 |
| FLUMAZENIL | 1MG/10ML (0.1MG/ML) | injectable · injection | RISING | Discontinued | 13 May 2008 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| FLUMAZENIL INJECTION | 02249561 | 0.1 MG / ML | SOLUTION · INTRAVENOUS | SANDOZ CANADA INCORPORATED |
| FLUMAZENIL INJECTION, USP | 02266342 | 0.1 MG / ML | SOLUTION · INTRAVENOUS | FRESENIUS KABI CANADA LTD |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FLUMAZENIL 0.5 MG/5 ML VIAL | $1.17913 | per ML | 19 Aug 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.